Maxima Biotech Inc.

Maxima was established in April 2019 with investment from Summed Taiwan. The company focuses on local development and production optimization of advanced minimally invasive surgical instruments. The core team has extensive practical experience in medical device distribution, product development, and innovation licensing. They possess the ability to integrate Taiwan's supply chain for mass production of minimally invasive instruments and market them internationally under a Taiwanese brand. Lastly, establishing the base by the successful experience of talented Taiwanese working on the Unmet Need then authorizing to worldly renowned companies. The industry faces challenges such as the global aging population trend, infection risks in medical device reuse, trade conflicts between the United States and China, supply chain disruptions caused by COVID-19, and the transfer of investment in innovation. These factors have created a gap in the market for a high-level medical device manufacturer with cost-effective solutions.